Intralesional Injection of Levofloxacin for the Management of Cutaneous Leishmaniasis

Clinical trial NCT06797544 · RECRUITING

Trial details

NCT number: NCT06797544
Sponsor: Hayder Adnan Fawzi
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous Leishmaniasis

Start date: 2025-02-09
Primary completion: 2025-11-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.